Cargando…

Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination

SIMPLE SUMMARY: Individuals with hematological diseases are particularly susceptible to COVID-19, and their vaccination has been a priority since the beginning of the pandemic. However, due to the disease itself or the treatment they receive, the protection achieved after vaccination may not be prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Mora, Sara, Pérez-Lamas, Lucía, Sainero, Miriam Solera, Torres, Montserrat, Sánchez-Menéndez, Clara, Corona, Magdalena, Mateos, Elena, Casado-Fernández, Guiomar, Alcamí, José, García-Pérez, Javier, Pérez-Olmeda, Mayte, Murciano-Antón, María Aranzazú, López-Jiménez, Javier, García-Gutiérrez, Valentín, Coiras, Mayte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137176/ https://www.ncbi.nlm.nih.gov/pubmed/37190272 http://dx.doi.org/10.3390/cancers15082344

Ejemplares similares

Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection
por: Vigón, Lorena, et al.
Publicado: (2022)

Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
por: Torres, Montserrat, et al.
Publicado: (2022)

Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19
por: Rodríguez-Mora, Sara, et al.
Publicado: (2022)

Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19
por: Rodríguez-Mora, Sara, et al.
Publicado: (2023)

Characterization of the Humoral and Cellular Immune Response Against the Natural Infection By Sars-Cov-2 in Oncohematological Patients with Post-COVID19 Autologous Transplantation
por: Sánchez-Tornero, Adrián, et al.
Publicado: (2021)

Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19
por: Corona De Lapuerta, Magdalena, et al.
Publicado: (2021)

PB1944: INDIVIDUALS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA SHOW IMPAIRED HUMORAL BUT NORMAL CELLULAR IMMUNE RESPONSES AFTER RECEIVING A COMPLETE VACCINATION SCHEDULE AGAINST SARS-COV-2
por: Sánchez-Menéndez, Clara, et al.
Publicado: (2023)

Analysis of Immunological and Clinical Response to Vaccination Against Sars-COV-2 in Patients with Chronic Myeloid Leukemia
por: ZURDO Castronuño, Alejandro, et al.
Publicado: (2022)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2
por: Perez, Laura, et al.
Publicado: (2023)

Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
por: Vigón, Lorena, et al.
Publicado: (2021)

Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity
por: Vigón, Lorena, et al.
Publicado: (2021)

IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle
por: Coiras, Mayte, et al.
Publicado: (2016)

Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IκBα and enhances HIV-1 replication in human T lymphocytes
por: Coiras, Mayte, et al.
Publicado: (2008)

Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers
por: Galán, Miguel, et al.
Publicado: (2022)

Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission
por: Vigón, Lorena, et al.
Publicado: (2020)

Sustained Cytotoxic Response of Peripheral Blood Mononuclear Cells from Unvaccinated Individuals Admitted to the ICU Due to Critical COVID-19 Is Essential to Avoid a Fatal Outcome
por: Casado-Fernández, Guiomar, et al.
Publicado: (2023)

Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection
por: Diez-Fuertes, Francisco, et al.
Publicado: (2022)

Basal shuttle of NF-κB/IκBα in resting T lymphocytes regulates HIV-1 LTR dependent expression
por: Coiras, Mayte, et al.
Publicado: (2007)

Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing
por: Montes, Marta, et al.
Publicado: (2015)

Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort
por: Vigón, Lorena, et al.
Publicado: (2022)

The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection
por: Rodríguez-Mora, Sara, et al.
Publicado: (2019)

PKCθ and HIV-1 Transcriptional Regulator Tat Co-exist at the LTR Promoter in CD4(+) T Cells
por: López-Huertas, María Rosa, et al.
Publicado: (2016)

Modifications in host cell structure and functions mediated by Tat intracellular expression are greatly dependent on the second exon
por: López-Huertas, María Rosa, et al.
Publicado: (2009)

Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity
por: Bedoya, Luis M., et al.
Publicado: (2016)

Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication
por: Coiras, Mayte, et al.
Publicado: (2013)

Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D(3) in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial
por: Cervero, Miguel, et al.
Publicado: (2022)

A Founder Effect Led Early SARS-CoV-2 Transmission in Spain
por: Díez-Fuertes, Francisco, et al.
Publicado: (2021)

Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
por: Torres, Montserrat, et al.
Publicado: (2022)

Identification of platelet refractoriness in oncohematologic patients
por: Ferreira, Aline Aparecida, et al.
Publicado: (2011)

Biosensors in Clinical Practice: Focus on Oncohematology
por: Fracchiolla, Nicola S., et al.
Publicado: (2013)

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
por: López-Huertas, María Rosa, et al.
Publicado: (2017)

Analysis of the -398C/T polymorphism in the perforin gene in oncohematological patients
por: Garcia, Fernanda Bernadelli, et al.
Publicado: (2011)

Importancia de la Ortografía en la Facultad de Pedagogía, de Poza Rica de Hidalgo, Ver. /
por: Pérez Vences, Mayte
Publicado: (1990)

La sociedad conyugal en los actos fiscales
por: Pérez Vences, Mayté
Publicado: (2008)

Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
por: Lendak, Dajana, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator
por: Lepe-Zuniga, Jose L., et al.
Publicado: (2018)

Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
por: Bug, Dmitrii S., et al.
Publicado: (2021)

Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication
por: Rodríguez-Mora, Sara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jrumlkuielhhbkf76gara6vr5m